SiCap wakes up consumers
ALBANY, N.Y. SiCap, makers of Sinus Buster capsaicin nasal spray, last week announced a new capsaicin-based energy spray called Spray Awake. According to the manufacturer, Spray Awake delivers caffeine in small, sustained amounts to reap positive results without the unwanted side effects associated with energy drinks, shots or pills.
“Oral sprays are the most efficient way to deliver sustained energy without jitters or a crash,” stated Scott Latella, SiCap director of sales. “The key is to ingest caffeine in small, sustained doses under the tongue so it doesn’t get broken down in the body. This exclusive Spray Awake formula provides a natural time-release element for caffeine delivery.”
Spray Awake uses a capsaicin extract to deliver sustained doses of caffeine in a sublingual dose. Capsaicin is derived from hot peppers, and it’s known to create super-permeability through the mucous membranes, the manufacturer stated.
“Although the capsaicin in Spray Awake is derived from peppers, it’s not spicy or overwhelming,” noted Wayne Perry, SiCap director of innovations. “This natural formula tastes like mint. The capsaicin actually soothes your mouth and throat while also quenching your thirst.”
Scientists find possible link between IBD, skin cancer
SAN DIEGO Findings from a new retrospective cohort study recently presented at the American College of Gastroenterology’s 74th Annual Scientific meeting here has found that patients with inflammatory bowel disease, especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing nonmelanoma skin cancer.
Lead researcher Millie Long, of the University of North Carolina, Chapel Hill, examined the records of 26,403 patients with Crohn’s disease, and 26,974 patients with ulcerative colitis, dating from 1996 through 2005.
According to the study findings, the incidence rate ratio of NMSC was higher in patients with IBD compared with their matched controls. In addition, recent use of any immunosuppressive medication (within 90 days) was associated with greater risk of NMSC, as was recent use of the thiopurine class of immunosuppressive medications and recent use of biologic medications in patients with Crohn’s disease.
“The increased risk of NMSC in patients with IBD is likely related to the immunosuppressive medications used to treat the disease, although we can’t rule out changes to the immune system itself as a result of IBD as contributing to this risk,” stated Long. “In patients on immunosuppression therapy after organ transplant, previous studies have shown a clear association with NMSC. Other studies have demonstrated that azathioprine, which is in the thiopurine class, can increase the photosensitization of human skin,” Long said.
“Our study demonstrates that patients with IBD on immunosupression may also be at risk for NMSC. As a result, our long-term management plans for IBD patients should stress the daily use of broad-spectrum sunscreen and increased awareness of NMSC to help to prevent complications,” Long said.
Study: Lactose intolerance is lower than expected among Americans
ROSEMONT, Ill. Prevalence of lactose intolerance may be far lower than previously estimated, according to a study in the latest issue of Nutrition Today published last week.
The study, which used data from a national sample of three ethnic groups, revealed that the overall prevalence rate of self-reported lactose intolerance is 12% – with 7.7% of European Americans, 10.1% of Hispanic Americans and 19.5% of African-Americans who consider themselves lactose intolerant.
These new findings indicate that previous estimates of lactose intolerance incidence – based on the incidence of lactose maldigestion – may be overestimated by wide margins. Previous studies have found lactose maldigestion, or low lactase activity in the gut, to occur in approximately 15% of European Americans, 50% of Mexican Americans and 80% of African Americans. The new study shows that lactose intolerance, based on self-reported data, may actually occur far less frequently than presumed.
“There’s so much confusion surrounding lactose intolerance,” stated Theresa Nicklas, of the USDA/ARS Children’s Nutrition Research Center at Baylor College of Medicine and lead study author. “By getting a better handle on the true number of people who deal with this condition every day, the nutrition community can be better equipped to educate and provide dietary guidance for Americans, including strategies to help meet dairy food recommendations for those who self-report lactose intolerance.”
Since increasing daily consumption of dairy can be an effective strategy for ensuring adequate intake of necessary nutrients (such as calcium, magnesium and potassium), those who do experience symptoms of lactose intolerance should know there are several practical solutions that can allow for consumption of milk and milk products.